Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2025-12-26 @ 3:20 AM
Study NCT ID:
NCT05216120
Status:
WITHDRAWN
Last Update Posted:
2023-07-03
First Post:
2022-01-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas
Sponsor:
HonorHealth Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-14
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-01-05
First Submit QC Date:
None
Study First Post Date:
2022-01-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-29
Last Update Post Date:
2023-07-03
Last Update Post Date Type:
ACTUAL